JPRN-UMIN000007700尚未招募未知
Development of new therapies in primary central nervous system lymphoma - Development of new therapies in PCNS
Department of Neurosurgery, Kurume University0 个研究点目标入组 50 人开始时间: 2012年4月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •positive for hepatitis B surface antigens, hepatitis C seropositivity, HIV disease or other immunodeficiencies, a Karnofsky performance score (KPS) of less than 50 for reasons not related to PCNSL, other malignant disease, and ongoing pregnancy or lactation.
研究者
相似试验
Unknown
2 期
BENDITA BEnznidazole New Doses Improved Treatment and AssociationsChagas DiseaseNCT03378661Drugs for Neglected Diseases210
进行中（未招募）
Unknown
Investigating the effects of intravenous fluids and imatinib in human volunteers with a sepsis-like stateInfections and InfestationsSepsisISRCTN16409847Belfast Health and Social Care Trust65
进行中（未招募）
Unknown
Study on novel treatment techniques for neurogenic gastrointestinal disorders utilizing the neuroendocrine axis and artificial intelligence technologyPreventing psychological illness in patients with neurogastroenteropathyNervous System DiseasesISRCTN11239735Chifeng Cancer Hospital100
已完成
不适用
Development of effective primary care treatment of severe sleep disorders in children with a learning disability; a randomised controlled trialSleep disorderslearning disabilityMental and Behavioural DisordersNonorganic sleep disordersISRCTN84194243HS R&D Regional Programme Register - Department of Health (UK)66
招募中
不适用
Development of treatment for neurological dysfunction using Brain-machine interface based on MEG and EEGeurological dysfunctionJPRN-UMIN000010180Osaka university40